These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34677420)

  • 1. Molecular Mechanisms of the SLC13A5 Gene Transcription.
    Li Z; Wang H
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.
    Li L; Li H; Garzel B; Yang H; Sueyoshi T; Li Q; Shu Y; Zhang J; Hu B; Heyward S; Moeller T; Xie W; Negishi M; Wang H
    Mol Pharmacol; 2015 Apr; 87(4):674-82. PubMed ID: 25628225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.
    Li Z; Li D; Choi EY; Lapidus R; Zhang L; Huang SM; Shapiro P; Wang H
    J Biol Chem; 2017 Aug; 292(33):13890-13901. PubMed ID: 28655760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes.
    Li Z; Li L; Heyward S; Men S; Xu M; Sueyoshi T; Wang H
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Metabolic Niche of Citrate Metabolism and
    Chen F; Willenbockel HF; Cordes T
    Metabolites; 2023 Feb; 13(3):. PubMed ID: 36984771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.
    Kopel JJ; Bhutia YD; Sivaprakasam S; Ganapathy V
    Biochem J; 2021 Feb; 478(3):463-486. PubMed ID: 33544126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the sodium-dependent citrate transporter SLC13A5 in mice causes alterations in brain citrate levels and neuronal network excitability in the hippocampus.
    Henke C; Töllner K; van Dijk RM; Miljanovic N; Cordes T; Twele F; Bröer S; Ziesak V; Rohde M; Hauck SM; Vogel C; Welzel L; Schumann T; Willmes DM; Kurzbach A; El-Agroudy NN; Bornstein SR; Schneider SA; Jordan J; Potschka H; Metallo CM; Köhling R; Birkenfeld AL; Löscher W
    Neurobiol Dis; 2020 Sep; 143():105018. PubMed ID: 32682952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells.
    Hu T; Huang W; Li Z; Kane MA; Zhang L; Huang SM; Wang H
    Toxicol Appl Pharmacol; 2020 Sep; 402():115117. PubMed ID: 32634519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth.
    Dirckx N; Zhang Q; Chu EY; Tower RJ; Li Z; Guo S; Yuan S; Khare PA; Zhang C; Verardo A; Alejandro LO; Park A; Faugere MC; Helfand SL; Somerman MJ; Riddle RC; de Cabo R; Le A; Schmidt-Rohr K; Clemens TL
    Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2212178119. PubMed ID: 36322718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular phenotypes segregate missense mutations in SLC13A5 Epilepsy.
    Jaramillo-Martinez V; Sennoune SR; Tikhonova EB; Karamyshev AL; Ganapathy V; Urbatsch IL
    bioRxiv; 2024 May; ():. PubMed ID: 38826402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity.
    Kopel J; Grooms A; Ganapathy V; Clothier J
    Psychiatr Genet; 2021 Feb; 31(1):32-35. PubMed ID: 33290383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.
    Hardies K; de Kovel CG; Weckhuysen S; Asselbergh B; Geuens T; Deconinck T; Azmi A; May P; Brilstra E; Becker F; Barisic N; Craiu D; Braun KP; Lal D; Thiele H; Schubert J; Weber Y; van 't Slot R; Nürnberg P; Balling R; Timmerman V; Lerche H; Maudsley S; Helbig I; Suls A; Koeleman BP; De Jonghe P;
    Brain; 2015 Nov; 138(Pt 11):3238-50. PubMed ID: 26384929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD.
    Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z
    J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Approaches to Studying SLC13A5 Disease.
    Beltran AS
    Metabolites; 2024 Jan; 14(2):. PubMed ID: 38392976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy.
    Goodspeed K; Liu JS; Nye KL; Prasad S; Sadhu C; Tavakkoli F; Bilder DA; Minassian BA; Bailey RM
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted Metabolomics of Slc13a5 Deficiency Reveal Critical Liver-Brain Axis for Lipid Homeostasis.
    Milosavljevic S; Glinton KE; Li X; Medeiros C; Gillespie P; Seavitt JR; Graham BH; Elsea SH
    Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization, tissue expression profile, and SNP analysis of porcine SLC13A5.
    Wang LY; Jiang J; Ma HM
    Genet Mol Res; 2015 Dec; 14(4):16090-101. PubMed ID: 26662401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281.
    Rives ML; Shaw M; Zhu B; Hinke SA; Wickenden AD
    Mol Pharmacol; 2016 Dec; 90(6):766-774. PubMed ID: 27754898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.